Table of Contents
The cannabis debate splits on evidence, not slogans. For use: modest evidence for chronic pain and multiple sclerosis symptoms; the approved drugs (Epidiolex, dronabinol, nabilone) treat specific conditions. Against: addiction (cannabis use disorder, adolescents 4–7x more likely), cognitive impairment with regular use, psychosis risk with a family history, impaired driving, and respiratory harm from smoking. The original’s “treating anxiety, depression, and seizures” overstated: seizures are treated by Epidiolex (a purified CBD drug), not by cannabis; anxiety and depression evidence is weak or mixed; arthritis pain evidence is preclinical. Legally, cannabis remains federally Schedule I in the US while most states have legalized medical or adult use — a split that persists into late 2026. The NCCIH cannabis evidence summary is the frame for all health claims on this site.
The debate, evidence-graded
| Argument | Evidence |
|---|---|
| Helps chronic pain | Modest benefit suggested |
| Treats anxiety/depression | Weak or mixed |
| Treats seizures | Epidiolex only, not the plant |
| Addictive | Established — CUD is real |
| Impairs cognition | Established with regular use |
| Legalization reduces harm | Debated; regulated markets vary |
History: Marihuana Tax Act 1937, Controlled Substances Act 1970 (Schedule I), state medical wave from 1996, adult-use wave from 2012. The FDA’s CBD regulatory position explains the federal framework. See our marijuana benefits and side effects guide and our cannabis impact guide.
Related
See our quitting cannabis guide and our cannabis glossary.
Frequently asked questions
Should people use cannabis?
A personal decision weighing modest pain/MS evidence against addiction, cognitive, and driving risks.
Does cannabis treat anxiety?
Weak or mixed evidence; it can worsen anxiety in some people.
Is cannabis legal?
Federally Schedule I in the US; most states have legalized medical or adult use.
Is cannabis addictive?
Yes — cannabis use disorder is real.
Does legalization reduce harm?
Debated; outcomes vary by market design and enforcement.
Browse the Cannabis Basics & Wellness hub.
Affiliate Disclosure
The CakeHeights Editorial Team is committed to providing accurate, research-backed information about cannabis and hemp products. Some links on this page are affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase through them. Our recommendations are based on independent research, testing, and analysis. We only promote products we believe offer genuine value to our readers. Learn more →